secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001193125-23-178075
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TScan CFO Brian Silver to step down effective July 21, 2023
-----------------------------------------------------------

- CFO and Treasurer Brian Silver resigns, effective July 21, 2023, to join an advisory firm in New York.
- Silver will continue to provide strategic advice to the company post-departure.
- Company has initiated a search for a successor chief financial officer.
- Silver noted financial runway into 2026 from convertible note, Amgen partnership, and follow-on financing.
- Resignation is not due to any disagreement with TScan's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312523178075/0001193125-23-178075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312523178075/d462412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-178075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer